METACARE CO., Ltd. (KRX:118000)
318.00
0.00 (0.00%)
At close: Sep 15, 2025
METACARE CO. Revenue
METACARE CO. had revenue of 5.76B KRW in the quarter ending June 30, 2025, with 18.37% growth. This brings the company's revenue in the last twelve months to 22.21B, up 20.22% year-over-year. In the year 2024, METACARE CO. had annual revenue of 20.21B with 17.10% growth.
Revenue (ttm)
22.21B
Revenue Growth
+20.22%
P/S Ratio
2.46
Revenue / Employee
716.45M
Employees
31
Market Cap
54.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.21B | 2.95B | 17.10% |
Dec 31, 2023 | 17.26B | -1.84B | -9.64% |
Dec 31, 2022 | 19.10B | 484.98M | 2.61% |
Dec 31, 2021 | 18.61B | 11.99B | 181.12% |
Dec 31, 2020 | 6.62B | -49.53B | -88.21% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |